Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice

[img]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB
[img]
Preview
PDF (Supplementary Materials) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
524kB

Item Type:Article
Title:Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice
Creators Name:Klocke, J. and Ulu, A. and Wu, K. and Rudolph, B. and Dragun, D. and Gollasch, M. and Schunck, W.H. and Hammock, B.D. and Riemekasten, G. and Enghard, P.
Abstract:Epoxy-fatty-acids (EpFAs), cytochrome P450 dependent arachidonic acid derivatives, have been suggested to have anti-inflammatory properties, though their effects on autoimmune diseases like systemic lupus erythematosus (SLE) have yet to be investigated. We assessed the influence of EpFAs and their metabolites in lupus prone NZB/W F1 mice by pharmacological inhibition of soluble epoxide hydrolase (sEH, EPHX2). The sEH inhibitor 1770 was administered to lupus prone NZB/W F1 mice in a prophylactic and a therapeutic setting. Prophylactic inhibition of sEH significantly improved survival and reduced proteinuria. By contrast, sEH inhibitor-treated nephritic mice had no survival benefit; however, histological changes were reduced when compared to controls. In humans, urinary EpFA levels were significantly different in 47 SLE patients when compared to 10 healthy controls. Gene expression of EPHX2 was significantly reduced in the kidneys of both NZB/W F1 mice and lupus nephritis (LN) patients. Correlation of EpFAs with SLE disease activity and reduced renal EPHX gene expression in LN suggest roles for these components in human disease.
Keywords:Biomarkers, Biopsy, Case-Control Studies, Animal Disease Models, Disease Progression, Enzyme Activation, Enzyme Inhibitors, Epoxide Hydrolases, Immunohistochemistry, Lipids, Lupus Nephritis, Inbred NZB Mice, Premedication, Prognosis, Animals, Mice
Source:Scientific Reports
ISSN:2045-2322
Publisher:Nature Publishing Group
Volume:9
Number:1
Page Range:8993
Date:20 June 2019
Official Publication:https://doi.org/10.1038/s41598-019-45299-5
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library